PPARγ and human metabolic disease

By R. Semple, V. Chatterjee, S. O’Rahilly. 2006

747 citations recorded by the source corpus.

Subfields: Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/171c81b0d6f6b4b09df49fbb7d13d3fda48c6ec8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Johan Auwerx
2. Mitchell A. Lazar
3. B. Spiegelman
4. L. Michalik
5. W. Wahli
6. Bart Staels
7. S. O’Rahilly
8. Christopher K. Glass

In Physiology

1. B. Spiegelman
2. Johan Auwerx
3. Mitchell A. Lazar
4. L. Michalik
5. W. Wahli
6. S. O’Rahilly
7. Christopher K. Glass
8. Takashi Kadowaki

Citations in the corpus

• International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors (2006, background): “…mutations that lead to a stereotyped syndrome of partial lipodystrophy and severe insulin resistance, as well as more common sequence variants with a much smaller impact on receptor function, have increased our understanding of the functions of PPAR (cid:4) in humans (Semple et al., 2006).”